Search
for
Sort by
Research 361–390 of 402
- Hair thread tourniquet syndrome in a male infant: a rare surgical emergency
- Advanced Lipotransfer Techniques
- Transforming By-Products into Functional Resources: The Potential of Cucurbitaceae Family Seeds in Cosmetics
- Tissue Engineering in Cosmetics and Dermatology: A New Era of Innovation and Application
- The Evolution of Emerging Nanovesicle Technologies for Enhanced Delivery of Molecules into and across the Skin
- Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management
- Dermatologic care of patients with differences of sex development
- The Transcriptional Regulator Prdm1 Is Essential for the Early Development of the Sensory Whisker Follicle and Is Linked to the Beta-Catenin First Dermal Signal
- Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents
- Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year
- Scrotal Rejuvenation
- Efficacy and safety of oral finasteride <i>versus</i> dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran
- Persistent Sexual and Psychological Symptoms After Finasteride Discontinuation: A Cross-Sectional Observational Study
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- An (Ir)reversible Affection of the Sexual Sphere: A Case Report
- Understanding the Secular Decline in Testosterone: Mechanisms, Consequences, and Clinical Perspectives
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Exploration of the Possible Relationships Between Gut and Hypothalamic Inflammation and Allopregnanolone: Preclinical Findings in a Post-Finasteride Rat Model.
- Post-finasteride syndrome - a true clinical entity?
- The Impact of Sulforaphane on Sex-Specific Conditions and Hormone Balance: A Comprehensive Review
- Navaratnas in Dermatology
- Dermatological care of gender‐diverse patients in Australia
- High-Dose Vitamin D3 and Tonsillectomy as Therapeutic Management in Henoch-Schönlein Purpura Following Hepatitis B Vaccination: A Rare Case Report.
- Evaluating the psychosocial impact of gender‐affirming dermatology treatments: A systematic review
- Comment on Current Investigations into the Postfinasteride Syndrome
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE
- Dermatological considerations for transgender and gender diverse patients: An Australian perspective
- Tourniquet syndrome in children (literature review and own observation)